Case Report: First case of synchronous androgen receptor-positive salivary duct carcinoma and prostate adenocarcinoma

病例报告:首例同步性雄激素受体阳性唾液腺导管癌和前列腺腺癌病例

阅读:1

Abstract

INTRODUCTION: The synchronous occurrence of two androgen receptor-positive (AR+) malignancies with overlapping metastatic patterns is exceedingly rare and poses significant diagnostic and therapeutic challenges. Salivary duct carcinoma (SDC) is an aggressive AR + tumor with a high propensity for early metastasis, whereas low-risk prostate adenocarcinomas (PCa) are often indolent. We report the first case of a synchronous SDC of the right parotid gland and a low-grade PCa, where the origin of osseous metastatic spread was initially unknown. CASE PRESENTATION: A 65-year-old male patient presented with progressive right-sided facial palsy and multiple osseous lesions. Initial histopathological assessment of the parotid mass and assignment of the metastases remained inconclusive. After performing a prostate-specific membrane antigen-positron emission tomography/computed tomography (PSMA-PET-CT) scan, a low-grade prostate adenocarcinoma (PCa) (Gleason 3 + 3) was diagnosed. Further pathological and imaging evaluation revealed an AR+, HER2-low, CK7-positive SDC. The extensive skeletal metastases were attributed to the SDC. CONCLUSION: This case shows the diagnostic complexity of synchronous AR + malignancies with overlapping metastatic profiles and emphasizes the need for integrated clinical, radiological, and pathological assessment to ensure optimal patient management. It highlights the need to biopsy metastatic bone lesions in cases of SDC-especially in older men-to rule out osseous metastases from more frequent carcinomas such as PCa.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。